Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Apr. 02, 2023
Apr. 03, 2022
Income Statement [Abstract]    
Revenue $ 21 $ 0
Cost of revenue 12,248 515
Gross margin (12,227) (515)
Operating expenses:    
Research and development 23,749 12,731
Selling, general and administrative 27,274 11,869
Total operating expenses 51,023 24,600
Loss from operations (63,250) (25,115)
Other income (expense):    
Change in fair value of convertible preferred stock warrants and common stock warrants (12,840) 67,800
Interest income, net 2,466 24
Other income (expense), net 21 (2)
Total other income (expense), net (10,353) 67,822
Net income (loss) and comprehensive income (loss) $ (73,603) $ 42,707
Net income (loss) per share, basic (in dollars per share) $ (0.47) $ 0.28
Weighted average number of common shares outstanding, basic (in shares) 155,626,977 151,648,439
Net loss per share, diluted (in dollars per share) $ (0.47) $ (0.16)
Weighted average number of common shares outstanding, diluted (in shares) 155,626,977 153,338,462